Blood treatment cassette with film valve and elastic spacer as well as blood treatment apparatus
10507277 ยท 2019-12-17
Assignee
Inventors
Cpc classification
A61M2205/3344
HUMAN NECESSITIES
A61M1/36225
HUMAN NECESSITIES
F16K7/12
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
A61M1/362223
HUMAN NECESSITIES
A61M1/362227
HUMAN NECESSITIES
A61M1/36226
HUMAN NECESSITIES
A61M2205/3337
HUMAN NECESSITIES
International classification
A61M1/30
HUMAN NECESSITIES
A61M1/36
HUMAN NECESSITIES
F16K7/12
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
Abstract
A blood treatment cassette having a cassette body comprising a hard part and a film that at least partially covers the hard part. The hard part comprises a valve base that cooperates with a section of the film adjacent the valve base to form a valve that is configured to be moved from a first open position in which the valve base and the section of the film do not touch each other to a second position in which the valve base and the section of the film touch each other when a force is applied to the section of the film. The blood treatment cassette comprises a spacer supported by the hard part, and the spacer is configured to apply, in the first position of the valve, force to the section of the film.
Claims
1. A blood treatment cassette having a cassette body comprising a hard part and a film, wherein the film is connected to the hard part and at least partially covers the hard part, wherein the hard part comprises a valve base that cooperates with a section of the film adjacent the valve base to form a valve, wherein the valve is configured to be moved from a first open position in which the valve base and the section of the film adjacent the valve base do not touch each other to a second position in which the valve base and the section of the film adjacent the valve base touch each other when a force is applied to the section of the film adjacent the valve base, wherein the blood treatment cassette comprises a spring element connected to the hard part, the spring element comprising at least two humps defining at least one groove or recess therebetween, the spring element being configured such that each of the at least two humps contacts and applies force to the section of the film adjacent the valve base when the valve is in the first open position.
2. The blood treatment cassette according to claim 1, wherein the spring element is spring-loaded.
3. The blood treatment cassette according to claim 1, wherein the spring element is elastic.
4. The blood treatment cassette according to claim 1, wherein the valve is configured to be moved from the first position into the second position by pressure applied on the valve by an actuator of a blood treatment apparatus to which the blood treatment cassette is connected.
5. The blood treatment cassette according to claim 1, wherein the valve is a film valve or phantom valve.
6. The blood treatment cassette according to claim 1, wherein the humps are integral elements of the spring element connected to the hard part.
7. The blood treatment cassette according to claim 6, wherein the spring element comprises a functional element.
8. The blood treatment cassette according to claim 7, wherein the functional element comprises one or more of a hydrophobic-membrane support-grid, a clot trap pad or a check valve.
9. The blood treatment cassette according to claim 7, wherein a gap is formed between the spring element and the functional element.
10. The blood treatment cassette according to claim 9, wherein the gap is in the form of a split or a groove.
11. The blood treatment cassette according to claim 1, wherein the valve base defines a recess having a depth that is 1 to 3 times the thickness of the film.
12. The blood treatment cassette according to claim 1, wherein the valve base behind an adjacent channel edge bar is recessed to about 1 to 3 times the thickness of the film, in the direction toward an interior of the cassette.
13. The blood treatment cassette according to claim 1, wherein the spring element comprises a recessed upper edge whose curve rises relative to the valve base a distance of 1 to 4 times the thickness of the film.
14. A system comprising: a blood treatment apparatus comprising an actuator-sensor-plate; and a blood treatment cassette configured to be connected to the blood treatment apparatus, the blood treatment cassette having a cassette body comprising a hard part and a film, wherein the film is connected to the hard part and at least partially covers the hard part, wherein the hard part of the blood treatment cassette comprises a valve base that cooperates with a section of the film adjacent the valve base to form a valve, and the valve is configured to be moved from a first open position in which the valve base and the section of the film adjacent the valve base do not touch each other to a second position in which the valve base and the section of the film adjacent the valve base touch each other when a force is applied to the section of the film adjacent the valve base, wherein the blood treatment cassette comprises a spacer supported by the hard part, wherein the spacer is configured to apply, in the first position of the valve, force to the section of the film adjacent the valve base, and wherein the actuator-sensor-plate of the blood treatment apparatus comprises at least one actuator having at least two part-actuators configured to apply force to the section of the film adjacent the valve seat independently from each other.
15. The system according to claim 14, wherein the actuator-sensor-plate of the blood treatment apparatus comprises three or more part-actuators.
16. The blood treatment cassette according to claim 1, wherein the at least one groove or recess defined between the at least two humps is configured to permit drainage of fluid between the spring element and the film when the at least two humps are in contact with the film.
17. The blood treatment cassette according to claim 1, wherein the at least two humps extend from a substantially planar surface of the spring element.
Description
BRIEF DESCRIPTION OF THE FIGURES
(1) The present invention shall be exemplarily explained in the following by way of the accompanying drawings, in which identical reference numerals designate same or similar elements. In the partially simplified figures:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14) The standard arrows in the figures indicate the direction of the blood stream. The block arrows indicate the respective direction of the substitute stream.
DETAILED DESCRIPTION
(15)
(16) In the following, the blood treatment cassette 1000 is also referred to as cassette 1000 in short.
(17) The cassette 1000 comprises a hard part 1. As it is exemplarily shown in
(18) The cassette 1000 of
(19) An embodiment involving a three-dimensional configuration of the welding and sealing contour is also possible.
(20) The cover device may close the chambers and/or channels of the hard part 1 of the cassette 1000, namely, against a side of the cover means facing away from the hard part 1 and/or against the atmosphere.
(21) As seen in
(22) The closed sealing bar 4 may alternatively be realized in an exposed manner.
(23) The film 3 may be connected to the hard part 1 of the cassette 1000 at additional local welds (not shown). These may also be closed or peripheral, i.e. closed in the sense of an enclosing limitation similar to a ring, and/or dot-shaped.
(24) The film 3 may locally be connected, e.g. welded, to the hard part 1 of the cassette 1000 in form of dots or a line, in particular at the edge zones of the liquid-conducting channels.
(25) The film 3 may be connected to the hard part 1 of the cassette 1000 by laser welding. If so, it is advantageous if the heat is locally applied while using a light-absorbing component. The light-absorbing component may be part of the material of the film 3 and/or of the hard part 1, or a layer disposed between film 3 and hard part 1 or above the film 3. The layer may be a film layer.
(26) The cassette 1000 may at least be coupled with a blood treatment apparatus (not shown in
(27) The cassette 1000 may be coupled with a coupling surface of the blood treatment apparatus by the plane of the film 3 or through the intermediary of the latter. The coupling area may preferably be executed three-dimensionally.
(28) The coupling surface of the blood treatment apparatus may be inclined to the rear, for instance at an upper portion thereof shown in
(29) The cassette 1000 comprises an arterial patient connection 7.
(30) The cassette 1000 comprises an arterial pressure measurement chamber 9. The latter may include corresponding sensors. The sensors may transmit signals, preferably through the intermediary of cables or cabling. The sensors may, however, also be provided to transmit signals in a wireless manner.
(31) The cassette 1000 comprises a connector 11 for the exit of blood from the cassette 1000 as well as a connector 13 for the entry of blood into the cassette 1000.
(32) The two connectors 11 and 13 are adapted to be connected to a pump tube segment or pump tube set of a blood pump.
(33) The cassette 1000 further comprises a chamber 15 including a pressure measurement site for pressure measurement in the extracorporeal blood circuit upstream from the dialyzer (pre-filter) or downstream from the pump (post-pump), respectively.
(34) At the chamber 15 the pressure in the extracorporeal circuit upstream from the dialyzer may be measured across the film 3 or via the film 3.
(35) The cassette 1000 comprises an arterial filter conduit 17 as well as a venous filter conduit 19.
(36) The interior of the cassette 1000 comprises a venous blood chamber 21. The venous blood chamber 21 is subdivided into an upper space 23 and a lower space 25.
(37) The upper space 23 of the venous blood chamber 21 may admit a laterally tangential inflow of blood. Here, blood may flow in laterally through the inlet (on the left side in
(38) The lower space 25 of the venous blood chamber 21 may represent a calming zone for the blood stream. Such a calming zone may possibly have substantially no rotational flow or no rotational flow of the blood present therein at all.
(39) The venous blood chamber 21 is subdivided into the upper space 23 and the lower space 25 by a cross-sectional restriction 27 of the hard part 1 of the cassette 1000. The cross-sectional restriction 27 reduces the cross-section of the venous blood chamber 21 in its width and depth so as to result in a shoot or rapid, whereby a fluid having traversed the cross-sectional restriction 27 will flow with slower flow velocity through venous blood chamber 21 of the cassette 1000. The upper space 23 and the lower space 25 are in fluid communication.
(40) By using such a construction, i.e., a subdivision of the venous blood chamber 21 into a zone with substantially or completely stable rotational flow of the blood and a calming zone for the blood stream, it is advantageously possible to achieve an efficient separation of air from the blood or fluid.
(41) Walls of the upper space 23 and of the lower space 25 of the venous blood chamber 21 may suitably be adapted to an inclination from the vertical position of the upper portion of the cassette 1000 in
(42) The cassette 1000 comprises a clot trap 29.
(43) The clot trap is preferably a clot trap as disclosed in the patent application (10 2009 024 495.6) having the title Gerinnselfnger, externe Funktionseinrichtung, Blutkreislauf sowie Behandlungsvorrichtung [Clot trap, external functional means, blood circuit and treatment apparatus] to the applicant of the present invention that was filed with the German Patent and Trademark Office on Jun. 10, 2009. The relevant disclosure thereof is herewith fully incorporated by way of reference.
(44) At the clot trap 29 it is possible to measure the pressure in the extracorporeal circuit through the film 3 or across the film 3, i.e., in particular after passage through the dialyzer or downstream of the dialyzer.
(45) The cassette 1000 comprises a venous patient connection 31.
(46) The cassette 1000 comprises an arterial heparin addition site 33. Here, it should be noted that the heparin addition site 33 (just like a venous heparin addition site 37) may also be suited and intended for adding other pharmacologically effective agents than heparin, which are only in a preferred manner anti-coagulants or combinations of active agents. This should also be noted whenever heparin is mentioned previously or in the following in any kind of context.
(47) The cassette 1000 comprises a check valve 35 at the arterial heparin addition site 33.
(48) Exemplary check valves for the use as check valve 35 of the arterial heparin addition site 33 and also as further check valves of the cassette 1000 are disclosed in the patent application to the applicant of the present invention (10 2009 024 469.7) having the title Ventilvorrichtung, Ventileinsatz, externe Funktionseinrichtung, Behandlungsvorrichtung sowie Verfahren [Valve device, valve insert, external functional means, treatment apparatus, and method] as filed with the German Patent and Trademark Office on Jun. 10, 2009, the relevant disclosure of which is herewith fully incorporated by way of reference.
(49) The cassette 1000 comprises an arterial heparin addition valve 36. By using the arterial heparin addition valve 36 the addition of heparin into the arterial filter conduit 17 may be controlled or regulated.
(50) The arterial heparin addition valve 36 may be configured as a so-called phantom valve.
(51) The expression phantom valve as used herein designates an element having an actor surface (in the present case, for example, an actor membrane) that may be reached by an actor that may adopt the function of a valve.
(52) The actor membrane can be made to move, dilate, curve, etc. in one direction by applying a force on it, e.g., a pressing force. As a result of its movement or dilatation, the actor membrane may come into contact with an element such as a sealing device, e.g. a bar, or move away from the latter. The actor membrane may thus, for example, effect or enhance or terminate or reduce a sealing effect.
(53) When the force acting on the actor membrane is ceased to apply or is released, the latter may return, for example, to a basic position, e.g., a non-bent condition.
(54) A phantom valve for use as an arterial heparin addition valve 36 as well as further phantom valves of the cassette 1000 may be configured with or from a bar portion of a channel at the hard part 1 of the cassette 1000 and a portion of the film 3 contacting or facing the bar portion.
(55) Phantom valves may be operated through actors of the blood treatment apparatus.
(56) In order to close a phantom valve, the portion of the film 3 may be pressed onto the bar portion. In order to open the phantom valve, the portion of the film 3 may again be raised or removed from the bar portion.
(57) Further examples of phantom valves may be found in the patent application 10 2009 012 632.5 having the title Abdichtungseinrichtung zum Abdichten eines Volumens einer medizinischen Behandlungsanordnung gegen ein weiteres Volumen sowie Anordnung und Verfahren [Sealing device for sealing a volume of a medical treatment arrangement against another volume, as well as arrangement and method], as filed with the German Patent and Trademark Office on Mar. 10, 2009 by the present applicant besides the patent application DE 100 53 441 A1 and the patent application DE 102 24 750 A1. The relevant disclosures thereof are herewith fully incorporated by way of reference.
(58) The cassette 1000 comprises a venous heparin addition site 37. The venous heparin addition site 37 may be configured as a Luer-connector.
(59) The cassette 1000 comprises a check valve 39 at the venous heparin addition site 37.
(60) The cassette 1000 comprises a venous heparin addition valve 40. With the aid of the venous heparin addition valve 40 the addition of heparin into the venous filter conduit 19 may be controlled or regulated.
(61) The cassette 1000 comprises a substituate addition site 41 or a substituate connector, respectively.
(62) The substituate addition site 41 may be a connection means as it is described in the patent application 10 2009 024 575.8 to the present applicant having the title Verbindungseinrichtung und Verfahren zum Verbinden wenigstens zweier fluidfhrender medizintechnischer Systeme, sowie medizintechnische Vorrichtung [Connection means and method for connecting at least two fluid-conducting medical-technical systems, as well as a medical-technical apparatus] as filed with the German Patent and Trademark Office on Jun. 10, 2009 by the present applicant. The relevant disclosure thereof is herewith fully incorporated by way of reference.
(63) The substituate addition site 41 may be provided with a touch-protection element (not shown). The substituate addition site 41 may be provided with a drip-protection element (not shown). The drip-protection element may be realized through an integrated closure sleeve. The drip-protection element may prevent residues of substituate and/or blood from dripping out when the cassette 1000 is released and subsequently removed from the blood treatment apparatus.
(64) The drip-protection element may be realized to be removable. It may be configured as a hood or lid.
(65) The substituate addition site 41 or some other portion of the cassette 1000 may moreover provide a tamper protection, as a result of which the user recognizes effortlessly, or at one glance, whether the cassette 1000 has already been used. This tamper protection may be realized by means of the touch-protection element, the closure sleeve, or some other structure. Preferably, the corresponding structure may recognizably change its position inside or relative to the cassette 1000. Preferably it may change its shape.
(66) Moreover, the substituate addition site 41 or some other portion of the cassette 1000 may provide a protection against reuse. In a preferred manner, the cassette 1000 is made unusable by means of a closure sleevepreferably in an irreversible mannerwith respect to an attempted reuse. If the cassette 1000 should nevertheless be used again, sensors of the blood treatment apparatus do not measure the signal characteristics that would be measured during use of a new cassette. This may be due to the fact that liquid cannot enter into the cassette 1000 or into the substituate addition site 41, or at least not in a sufficient or usual quantity. The control unit of the blood treatment apparatus may recognize this. A warning may be triggered.
(67) As a tamper protection or a protection against reuse it is preferably possible to use a tamper protection or protection against reuse as disclosed by the applicant of the present invention in the patent application (10 2009 024 575.8) having the title Verbindungseinrichtung and Verfahren zum Verbinden wenigstens zweier fluidfhrender medizintechnischer Systeme, sowie medizintechnische Vorrichtung [Connection means and method for connecting at least two fluid-conducting medical-technical systems, as well as a medical-technical apparatus] that was filed with the German Patent and Trademark Office on Jun. 10, 2009. The relevant disclosure thereof is herewith fully incorporated by way of reference.
(68) The cassette comprises a connector 43 for the exit of substituate from the cassette 1000 as well as a connector 45 for the entry of substituate into the cassette 1000.
(69) The connectors 43 and 45 are adapted to be connected to a pump tube segment or a pump tube set of a substituate pump.
(70) The cassette 1000 comprises a check valve 47 for the addition of substituate.
(71) Substituate may be introduced into a substituate conduit 49 by operating the check valve 47.
(72) The cassette 1000 comprises a pre-dilution addition valve 51. The pre-dilution addition valve 51 may be configured as a phantom valve.
(73) The cassette 1000 comprises a post-dilution addition valve 53. The post-dilution addition valve 53 may be configured as a phantom valve.
(74) The cassette 1000 comprises a single-needle sterile membrane 55.
(75) The cassette 1000 comprises a single-needle chamber 57. In
(76) Inside the single-needle chamber 57 a blood surge redirection element 59 is arranged. The blood surge redirection element 59 may serve for decelerating a blood surge and/or extinguishing its impulse.
(77) A connection to an inside of the single-needle chamber 57 may be provided by means of connection means as disclosed by the applicant of the present invention in the patent application (10 2009 024 467.0) having the title Einrichtung sowie externe Funktionseinrichtung und Behandlungsvorrichtung zum Behandeln von medizinischen Fluiden [Device and external functional means and treatment apparatus for the treatment of medical fluids] that was filed with the German Patent and Trademark Office on Jun. 10, 2009. The relevant disclosure thereof is herewith fully incorporated by way of reference.
(78) The cassette 1000 comprises a single-needle blood valve 61. The single-needle blood valve 61 may be configured as a phantom valve.
(79) The cassette 1000 comprises an evacuation site 63. The evacuation site 63 may serve for vacuum coupling of the cassette 1000 to the blood treatment apparatus as is described, for example, in the patent application DE 10 2007 042 964 A1 having the title Vorrichtung und Verfahren zur Behandlung einer medizinischen Flssigkeit [Apparatus and method for treating a medical liquid] that was filed with the German Patent and Trademark Office on 10 Sep. 2007. The relevant disclosure thereof is herewith fully incorporated by way of reference.
(80) The cassette 1000 comprises a primary alignment center 65. The primary alignment center 65 may advantageously serve for aligning and/or latching of the cassette 1000 on the blood treatment apparatus.
(81) The cassette 1000 comprises a secondary alignment site 67. The secondary alignment site 67 may serve for aligning and/or latching of the cassette 1000 on the blood treatment apparatus.
(82) The cassette 1000 is filled with gas (e.g., sterile air) prior to beginning priming. During priming of the extracorporeal blood circuit this gas filling has to be displaced. Insofar, a blood treatment cassette generally represents a particular challenge as there are both rising and falling conduits and moreover chambers in which no air nests must remain. For this purpose, the present cassette 1000 is provided with special construction features.
(83) The chamber 15 for measuring the arterial pressure is constructed such that air may rise into a pump tube segment (e.g. into the pump tube segment). Advantageously, there are no dead spaces present. Air rising by itself from the arterial pressure measurement chamber into the pump tube segment of the blood pump is forcibly conveyed through the pump tube segment from the engagement range of the blood pump (e.g., by the rollers of a roller pump). As soon as the pump ceases to exert an influence (for example due to disengaging the rollers), the air rises by itself into the cassette 1000 in the conveying direction.
(84) The venous recirculation conduit (or a venous portion of the extracorporeal circuit) is a downward conduit. Starting from a particular prevailing volume flow (e.g., 200 ml/min in the case of the cassette 1000 shown in
(85) In the venous blood chamber 21 large cross-sections are provided, such that air bubbles may reliably rise there against the main direction of flow due to the slower or lower flow velocities present in this location.
(86) Further constructive features of the cassette 1000 are as follows:
(87) The phantom valves 40, 51 and 53 are arranged such that blood (which has a higher density than water or substituate etc.) can hardly penetrate upward or sideways into opened phantom valves while the cassette 1000 is operated with blood, for the latter descends as compared to the lighter water. Such an advantageous orientation is achieved with the aid of the phantom valves 40, 51, and 53. The valve 36, on the other hand, does not imply such a requirement, i.e., the orientation is not crucial there.
(88) For the same reason, the conduit channel (stub channel) below the check valve 47 for adding substituate is constructed or arranged in a rising manner. In the event of a malfunction of the pre- and/or post-dilution valves 51 and 53 and a resulting bypass flow of blood, blood cannot rise into the substituate conduit 49 anymore. The blood will rather flow past the opening of the corresponding stub conduit.
(89) The inclination of the cassette 1000 preferably is from 5 degrees to 11 degrees, in a particularly preferred manner it assumes the 8 degrees already mentioned above.
(90) Reference numeral 288 denotes a phantom valve which allows in the first position a flow in the chamber 202 or prevents it in a second position. In its simplest embodiment, a phantom valve is a film valve through which a fluid path, between hard part 1 and the section of the film disposed above it, is prevented through temporary pressing of the film 2 on a valve base, like a bar or other sections of the hard part 1, and reopened after release of the pressing force.
(91) The reference numeral 202, 204, 226 and 231 are elucidated in the description of
(92)
(93) As is shown in
(94) Here, it is clearly seen that the cassette 1000 comprises a sealing bar 69. The sealing bar 69 may be employed, for example, for realizing the pre-dilution addition valve 51.
(95)
(96) The cassette 1000 comprises a single-needle air connector 71. It may be provided to arrange a support grid (not shown) of the single-needle sterile membrane 55 at the single-needle air connector 71 on the apparatus side and/or on the blood side.
(97) The cassette 1000 comprises several support bars. The support bars have different heights relative, e.g., to the plane of the film 3. The support bars are projected in the side of the cassette 1000 facing the observer in
(98) The cassette 1000 comprises support bars 73 having a height of 5 mm, support bars 75 having a height of 8 mm, support bars 77 having a height of 13 mm, support bars 79 having a height of 24 mm, and support bars 81 having a height of 31 mm. These and other numeric values should, of course, be understood as mere examples.
(99) The support bars may serve to support the cassette, in the state of being coupled to a blood treatment apparatus, against a lid of a reception portion of the blood treatment apparatus for receiving the cassette. Exemplary embodiments of such a coupling of the cassette to the blood treatment apparatus are given in the patent application 10 2009 012 633.3 having the title Vorrichtung zum Verbinden einer externen Funktionseinrichtung mit einer Anordnung, Anordnung aufweisend eine solche Vorrichtung and Verfahren zum Verbinden [Device for connecting an external functional means to an arrangement, arrangement including a like apparatus, and connecting method] as filed with the German Patent and Trademark Office on Mar. 10, 2009, the relevant disclosure of which is herewith fully incorporated by way of reference.
(100) In
(101) The upwardly-facing surfaces of the venous blood chamber 21 and of the single-needle chamber 57 accordingly comprise such an inclination that air bubbles may still reliably rise on the inside despite the inclination of the cassette 1000. As an alternative, a cassette design which does not provide any inclination of the cassette is, of course, basically also possible.
(102) The following figures show sections of a cassette 1000 which may by all features be in accordance with the cassette 1000 of
(103)
(104)
(105)
(106) In order to fulfil the function of alignment, placing and springing of the humps 229a, 229b, it is preferred that the spring element 227a, 227b is made of similar material as the hard part 1 (e.g. of thermoplast, preferably with a flexural-E-Modulus of circa 800 to 2000 N/mm.sup.2).
(107) Due to its favourable shaping, the spring element 227a, 227b may advantageously be produced extremely cost-effective in open/close multi-injection molding tools.
(108)
(109) The spring element 227a, 227b is positioned and fixed in the example of
(110) Optionally provided support humps 233 of the hard part 1, see
(111) On the other side of the support ribs 234i.e. in the direction of the front section or spring clamp 228 of the spring element 227a, 227bthe latter comprises no more support ribs 234. Due to its thin shaping and its secured spacing to the ground and to the walls of the chamber 202, the spring element 227a, 227b may spring freely and elastically.
(112) In the exemplary embodiment of the
(113)
(114) The section 226 encompasses the film valve sealing seat-bar as a valve base of a valve or film valve 288 designed as phantom valve at which the film 3 is not glued to or welded on the section of the hard part 1 disposed underneath it (or at which the section of the hard part 1 arranged above the film 3 is not glued to or welded on the film 3).
(115) The section 226 may be straight (i.e. with a straight upper edge) or dented (i.e. with concave or convex, but in any case dented upper edge). In the purely exemplary dented embodiment which is shown in
(116) In the illustrated exemplary case of the
(117) In connection with the low split 235 between the spring element 227a, which preferably corresponds to 2 to 6 times the thickness or strength of the film 3 and due to the high number of humps 229a on the spring element 227a, a large flow cross section connection advantageously is achieved by low dent-depth T of about 1 to 3 times of the film strength between the channel 201 and the chamber 202. By closing the machine door, the cross section connection is closed by a film hub corresponding to only 2 to 4 times of the film strength.
(118) Due to this elastical arrangement of the humps 229a, 229m in addition to the large dimension of the flow cross section, an undesired closing of the valve 288 in the area of the section 226 during the production of the cassette 1000 and up to the completion of the gas sterilization, is particularly effectively prevented. This is also because the spring element 227a, 227b, is designed against overload due to bending technique due to its design and due to its securely embodied path limitation on the ground of the chamber 202 and that the film 3 always lifts up from the dent base 281 even if the film 3 should already have a prior damage in the shape of dents.
(119) Due to the support ribs 234, the free-bending spring arm 228a as well as the humps 229a, 229m having drainage grooves 230 in between, the spring element 227a 227b may have a direct contact with the hard part 1 and with film 3 only at few points whose overall surface is only few square millimeter (mm.sup.2). In this way, the gas sterilization of all relevant surfaces is advantageously ensured.
(120)
(121) In this embodiment, the section 226 or the film valve-sealing seat-bar or the valve base is bent and comprises humps 229m which do not overtop the level of the film 3.
(122) In
(123) The marginal or edge-sided humps 229a and edges or angles 282 (see
(124)
(125) In
(126) Thereby, an assembling tolerance balance or compensation results between cassette 1000 and blood treatment apparatus. Further, the valve sealing press force spreads durably and evenly on the entire valve base during use. For generating a relaxation-free force, exemplary spiral springs 243 made of spring steel which are easily inserted in and biased by a pocket or slot of the actuator-sensor-plate 290 during the assembling of the pressure stamp 240 are here provided. The complete pressure stamp 240 may be produced at low cost from unreinforced or fiber-reinforced thermoplastics in open/close injection molding tools.
(127) It should be noted that the valve base or the valve-sealing seat-bar of the section 226 does not necessarily have to be dented. A straight course of the valve base is also encompassed by the present invention.
(128) TABLE-US-00001 List of Reference Numerals Reference Numeral Description 1000 cassette 1 hard part 3 film 4 sealing bar 5 closed or peripheral weld 9 arterial pressure measurement chamber 11 connector for the exit of blood from cassette 1000 13 connector for the entry of blood into cassette 1000 15 chamber with arterial post-pump, or pre-filter, pressure measureent site 17 arterial filter conduit 19 venous filter conduit 21 venous blood chamber 23 upper space of the venous blood chamber 21 25 lower space of the venous blood chamber 21 27 cross-sectional restriction of the hard part 1 29 clot trap 31 venous patient connection 33 arterial heparin addition site 35 check valve of arterial addition site 33 36 arterial heparin addition valve (phantom valve) 37 venous heparin addition site 39 check valve of the venous heparin addition site 40 venous heparin addition site (phantom valve) 41 substituate addition valve 43 connector for exit of substituate from the cassette 1000 45 connector 45 for entry of substituate into the cassette 1000 47 check valve for addition of substituate 49 substituate conduit 51 pre-dilution addition valve (phantom valve) 53 post-dilution addition valve (phantom valve) 55 single-needle sterile membrane 57 single-needle chamber 59 blood surge redirection element 61 single-needle blood valve (phantom valve) 63 evacuation site for vacuum coupling 65 primary alignment center 67 secondary alignment site 69 sealing bar 71 single-needle air connector 73 support bars having a height of 5 mm 75 support bars having a height of 8 mm 77 support bars having a height of 13 mm 79 support bars having a height of 24 mm 81 support bars having a height of 31 mm 87 blood pump 89 substituate pump 90 pump tube segment of substituate pump 89 93 venous portion of extracorporeal circuit 3000 103 venuos needle 105 blood inlet at the dialyzing device 2000 107 blood outlet from the dialyzing device 2000 109 single-needle access to patient 4000 201 channels 202 chamber 204 closed, flat channel edge bars 226 section or film sealing seat-bar or valve seat or valve base 227a, 227b spring element or disposable spring element 228 spring clamp 228a spring arm or cantilever 229a, 229m humps 230 drainage groove 231 fixing pin 232 fixing bores 233 support humps 234 support ribs 235 split 237 height difference or flow cross section 240 Actuator; pressure stamp 241 actuator, bending joints 242 part-actuator; part-pressure stamp 243 spiral spring 280 hydrophobic membrane-support grid 281 dent base 282 Angles or edges 288 phantom or film valve 290 actuator-sensor-plate